BR Biopharma, Inc. (BRBI) to Issue Quarterly Dividend of $0.15 on June 5th

BR Biopharma, Inc. (NASDAQ:BRBI) announced a quarterly dividend on Friday, May 8th. Stockholders of record on Tuesday, May 19th will be paid a dividend of 0.147 per share on Friday, June 5th. This represents a c) dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date is Tuesday, May 19th.

BR Biopharma Stock Performance

Shares of NASDAQ BRBI opened at $14.41 on Friday. BR Biopharma has a 12 month low of $12.15 and a 12 month high of $67.01. The stock’s 50 day moving average price is $14.80.

BR Biopharma (NASDAQ:BRBI) last issued its quarterly earnings data on Tuesday, March 31st. The company reported $0.09 EPS for the quarter. The firm had revenue of $25.95 million for the quarter.

Institutional Investors Weigh In On BR Biopharma

A hedge fund recently bought a new stake in BR Biopharma stock. Acuitas Investments LLC purchased a new stake in BR Biopharma, Inc. (NASDAQ:BRBI) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 3,000 shares of the company’s stock, valued at approximately $45,000. BR Biopharma accounts for approximately 3.2% of Acuitas Investments LLC’s portfolio, making the stock its 7th biggest holding.

About BR Biopharma

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.